Molecular Mechanisms Affecting Statin Pharmacokinetics after Bariatric Surgery
- PMID: 39408705
- PMCID: PMC11476770
- DOI: 10.3390/ijms251910375
Molecular Mechanisms Affecting Statin Pharmacokinetics after Bariatric Surgery
Abstract
According to recent data, one in eight people in the world struggle with obesity. Obesity management is increasingly dependent on bariatric surgical interventions, as the combination of lifestyle modifications and pharmacotherapy could have a modest long-term effect. Surgery is recommended only for individuals whose body mass index (BMI) ≥ 40 kg/m2 and ≥ 35 kg/m2 in the presence of weight-related comorbidities. The most commonly performed procedures are sleeve gastrectomy and roux-en-Y gastric bypass. Pharmacokinetic and pharmacodynamic alterations occur as a result of the anatomical and physiological changes caused by surgery, which further differ depending on physicochemical drug factors and factors related to the dosage form. The following modifications are distinguished based on the type of bariatric surgery performed. Most bariatric patients have accompanying comorbidities, including dyslipidemia treated with hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors or statins. Significant improvements in the lipid profile are observed early in the postoperative period. The data reported in this review on statin pharmacokinetic alterations have demonstrated substantial inter- and intravariability, making it difficult to adopt clear guidelines. Based on the current literature review, reducing the statin dose to the lowest effective with continuous monitoring is considered an optimal approach in clinical practice.
Keywords: bariatric surgery; dyslipidemia; hydroxymethylglutaryl-CoA reductase; hypolipidemic agents; inhibitors; medication management; obesity.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Effects of statin therapy on weight loss and diabetes in bariatric patients.Surg Obes Relat Dis. 2017 Apr;13(4):674-680. doi: 10.1016/j.soard.2016.11.018. Epub 2016 Nov 23. Surg Obes Relat Dis. 2017. PMID: 28159561
-
Bariatric surgery: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1. Ont Health Technol Assess Ser. 2005. PMID: 23074460 Free PMC article.
-
A risk stratification analysis of atherosclerotic cardiovascular disease events post-statin discontinuation in patients who underwent sleeve gastrectomy or Roux-en-Y gastric bypass bariatric/metabolic surgeries.Surgery. 2024 Sep;176(3):597-604. doi: 10.1016/j.surg.2024.05.024. Epub 2024 Jun 19. Surgery. 2024. PMID: 38902126
-
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410. Health Technol Assess. 2009. PMID: 19726018 Review.
-
Surgery for weight loss in adults.Cochrane Database Syst Rev. 2014 Aug 8;2014(8):CD003641. doi: 10.1002/14651858.CD003641.pub4. Cochrane Database Syst Rev. 2014. PMID: 25105982 Free PMC article. Review.
References
-
- World Health Organization Obesity and Overweight. [(accessed on 10 February 2024)]; Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
-
- Mohajan D., Mohajan H.K. Body Mass Index (BMI) Is a Popular Anthropometric Tool to Measure Obesity among Adults. J. Innov. Med. Res. 2023;2:25–33. doi: 10.56397/JIMR/2023.04.06. - DOI
-
- Jensen M.D., Ryan D.H., Apovian C.M., Ard J.D., Comuzzie A.G., Donato K.A., Hu F.B., Hubbard V.S., Jakicic J.M., Kushner R.F., et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. Circulation. 2013;129:S102–S138. doi: 10.1161/01.cir.0000437739.71477.ee. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials